Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?
Orthocell (ASX:OCC) shares notched upwards on Friday as the company announced its nerve repair product has been...
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online